Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Tomaszuk, Anna" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
How to deal with patients with atrial fibrillation during the COVID-19 epidemic?
Autorzy:
Tomaszuk-Kazberuk, Anna
Powiązania:
https://bibliotekanauki.pl/articles/895751.pdf
Data publikacji:
2020-05-29
Wydawca:
Gdański Uniwersytet Medyczny
Tematy:
atrial fibrillation
coronavirus
SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus-2
COVID-19 (Coronavirus disease 2019)
NOAC
Opis:
Patients with atrial fibrillation (AF) due to old age and comorbidities are at a higher risk of SARS-CoV-2 infection. These patients should protect themselves by limiting contact with other people to an absolute minimum and they should be educated about hygiene, including careful hand washing. In general, the principles of antiarrhythmic drug treatment of quarantined, infected and asymptomatic individuals remain unchanged. In the hospital setting it is important to remember about possible interactions between antibiotics, anticoagulants, antiarrhythmic, antiviral and antimalarial drugs. The current pandemic also led to limitations regarding the implantation and control of implantable devices to an absolute minimum.
Źródło:
European Journal of Translational and Clinical Medicine; 2020, 3, 1; 53-59
2657-3148
2657-3156
Pojawia się w:
European Journal of Translational and Clinical Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Postponed absorption of dabigatran in a patient with paralytic ileus – difficulties in decision making on reversal agent (idarucizumab) use
Autorzy:
Tomaszuk-Kazberuk, Anna
Łopatowska, Paulina
Młodawska, Elżbieta
Klaja, Beata
Ausztol, Paulina
Korbel, Bolesław
Sobkowicz, Bożena
Powiązania:
https://bibliotekanauki.pl/articles/895831.pdf
Data publikacji:
2019-06-04
Wydawca:
Gdański Uniwersytet Medyczny
Tematy:
idarucizumab
dabigatran
paralytic ileus
absorption
Opis:
According to the European Society of Cardiology (ESC) guidelines, non-vitamin K antagonist oral anticoagulants (NOACs) are first choice drugs in prevention of thromboembolic events among patients with atrial fibrillation (AF). According to our knowledge this was the only case of delayed absorption of dabigatran due to ileus. A 79-year-old woman with hypertension and a 1-year history of persistent AF treated with dabigatran (a direct thrombin inhibitor approved for the prevention of stroke in patients with non-valvular AF) 110 mg bid for two weeks. She was hospitalized due to acute abdominal pain, vomiting and diarrhea. Signs of acute embolism of abdominal aorta (paraparesis) were confirmed on contrast-enhanced computed tomography scan and she was qualified for emergency surgery. The use of idarucizumab, the specific reversal agent for dabigatran, was considered twice. This case shows that exposure to dabigatran may occur later in patient with acute ileus due to alterations in absorption than it can be expected in normal situation. Such patients should be carefully monitored for a significant rebound in anticoagulant activity.
Źródło:
European Journal of Translational and Clinical Medicine; 2019, 2, 1; 44-47
2657-3148
2657-3156
Pojawia się w:
European Journal of Translational and Clinical Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies